THERAPY FOR TREATMENT OF MEDIAL KNEE ARTHRITIS
治疗内侧膝关节炎的疗法
基本信息
- 批准号:7606239
- 负责人:
- 金额:$ 10.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-01-03 至 2007-11-30
- 项目状态:已结题
- 来源:
- 关键词:AffectArthritisBraces-Orthopedic appliancesClinical TrialsComputer Retrieval of Information on Scientific Projects DatabaseDegenerative polyarthritisFollow-Up StudiesFundingGenerationsGoalsGrantInstitutionInterventionKneeKnee OsteoarthritisLabelLateralMedialMedicalModalityMotionOrthotic DevicesPainPatientsPlacebosRandomizedResearchResearch PersonnelResourcesScoreShoesSourceStressTestingTimeUnited States National Institutes of HealthUse EffectivenessWeekWeight-Bearing stateWomanimproved functioningmen
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The medial compartment absorbs 60-70% of the force across the knee during weight bearing and is subjected to more stress than the lateral compartment. Osteoarthritis affects the medial tibiofemoral compartment much more often than the lateral in both men and women. Since involvement of this compartment is especially frequent, interventions whose goal is to realign the knee so as to reduce transarticular loading on the medical compartment, such as valgus bracing are sometimes used clinically. Despite knowing for many years that altering loads in patients with knee OA may be a safe, inexpensive and an effective modality of treatment, there have been few studies that have evaluated these therapies, and these studies are either small or have other methodologic limitations.
The objective of this 3-year project is to determine whether the provision of realignment therapy in patients with medial knee OA relieves knee pain and improves function. We will test the hypothesis that compared to control treatment; the use of realignment therapy (valgus knee brace + motion control shoes + orthosis) is effective in medial knee OA.
Study aims are:
-To undertake a 16-week, randomized crossover clinical trial in patients with medial knee osteoarthritis to determine whether provision of realignment therapy leads to lower pain scores and improved function during the time of this treatment than during the use of a placebo treatment;
-To perform an open label follow-up study to track use and effectiveness of treatment. This project will be co-funded by Generation II, a knee bracing company.
这个子项目是众多研究子项目之一
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David John HUNTER其他文献
David John HUNTER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David John HUNTER', 18)}}的其他基金
Discovery, Biology and Risk of Inherited Variants in Breast Cancer
乳腺癌遗传变异的发现、生物学和风险
- 批准号:
7933407 - 财政年份:2010
- 资助金额:
$ 10.63万 - 项目类别:
A RANDOMIZED TRIAL OF REALIGNMENT THERAPY FOR TREATMENT OF MEDIAL KNEE ARTHRITIS
治疗膝关节内侧关节炎的重新调整疗法的随机试验
- 批准号:
7379493 - 财政年份:2005
- 资助金额:
$ 10.63万 - 项目类别:
Fenoldopam: Effect and Contrast-Induced Renal Impairment
非诺多泮:效果和对比剂引起的肾损伤
- 批准号:
7041937 - 财政年份:2003
- 资助金额:
$ 10.63万 - 项目类别:
Folate, 1-Carbon Nutrients, Gene Variants & Colon Cancer
叶酸、1-碳营养素、基因变异
- 批准号:
7119203 - 财政年份:2003
- 资助金额:
$ 10.63万 - 项目类别:
Folate, 1-Carbon Nutrients, Gene Variants & Colon Cancer
叶酸、1-碳营养素、基因变异
- 批准号:
6801920 - 财政年份:2003
- 资助金额:
$ 10.63万 - 项目类别:
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3
表征乳腺癌和前列腺癌的遗传易感性;
- 批准号:
7502076 - 财政年份:2003
- 资助金额:
$ 10.63万 - 项目类别:
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3
表征乳腺癌和前列腺癌的遗传易感性;
- 批准号:
7658858 - 财政年份:2003
- 资助金额:
$ 10.63万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
Tissue tropism of PD-1 therapy in ulcerative colitis and rheumatoid arthritis
PD-1治疗溃疡性结肠炎和类风湿性关节炎的组织向性
- 批准号:
MR/Y009681/1 - 财政年份:2024
- 资助金额:
$ 10.63万 - 项目类别:
Fellowship
Do autoantibodies to aberrantly glycosylated MUC1 drive extra-articular rheumatoid arthritis, and can GSK assets prevent driver antigen formation?
针对异常糖基化 MUC1 的自身抗体是否会导致关节外类风湿性关节炎,GSK 资产能否阻止驱动抗原形成?
- 批准号:
MR/Y022947/1 - 财政年份:2024
- 资助金额:
$ 10.63万 - 项目类别:
Research Grant
Preclinical development of an extracellular vesicle biotherapeutic for juvenile idiopathic arthritis
幼年特发性关节炎细胞外囊泡生物治疗药物的临床前开发
- 批准号:
10068495 - 财政年份:2024
- 资助金额:
$ 10.63万 - 项目类别:
Collaborative R&D
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 10.63万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Exploring the inflammatory mediators degraded by MMP-2 in MMP-2-deficient mice with knee arthritis through a novel TMT-TAILS quantitative proteomics
通过新型 TMT-TAILS 定量蛋白质组学探索 MMP-2 缺陷型膝关节炎小鼠中 MMP-2 降解的炎症介质
- 批准号:
24K19850 - 财政年份:2024
- 资助金额:
$ 10.63万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of an adaptive platform trial to prevent Rheumatoid Arthritis in partnership with First Nations People.
与原住民合作开发预防类风湿关节炎的适应性平台试验。
- 批准号:
491810 - 财政年份:2023
- 资助金额:
$ 10.63万 - 项目类别:
Operating Grants
The role of diet, as mediated by the gut microbiome, on childhood arthritis disease activity: a feasibility intervention study.
肠道微生物组介导的饮食对儿童关节炎疾病活动的作用:一项可行性干预研究。
- 批准号:
489316 - 财政年份:2023
- 资助金额:
$ 10.63万 - 项目类别:
Operating Grants
Investigation of hypoxia-inducible factor-1 (HIF-1) as a novel therapeutic target for juvenile idiopathic arthritis.
研究缺氧诱导因子-1 (HIF-1) 作为幼年特发性关节炎的新治疗靶点。
- 批准号:
23K14987 - 财政年份:2023
- 资助金额:
$ 10.63万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
DEMORA: DEep spatial characterization of synovial MacrOphages in Rheumatoid Arthritis
DEMORA:类风湿性关节炎滑膜巨噬细胞的深度空间特征
- 批准号:
EP/Y027760/1 - 财政年份:2023
- 资助金额:
$ 10.63万 - 项目类别:
Fellowship
The roles and mechanisms of inflammation resolution in the development of Rheumatoid Arthritis
炎症消退在类风湿关节炎发展中的作用和机制
- 批准号:
10733789 - 财政年份:2023
- 资助金额:
$ 10.63万 - 项目类别: